Open Access

Cell‑specific histone modifications in atherosclerosis (Review)

  • Authors:
    • Wanlin Jiang
    • Devendra K. Agrawal
    • Chandra S. Boosani
  • View Affiliations

  • Published online on: June 6, 2018     https://doi.org/10.3892/mmr.2018.9142
  • Pages: 1215-1224
  • Copyright: © Jiang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Histone modifications are the key epigenetic mechanisms that have been identified to regulate gene expression in many human diseases. However, in the early developmental stages, such as in utero and the postnatal stages, histone modifications are essential for gene regulation and cell growth. Atherosclerosis represents a classical example of the involvement of different cell types, and their cumulative effects in the development of atheroma and the progression of the disease. Post translational modifications on proteins either induces their functional activity or renders them inactive. Post translational modifications such as methylation or acetylation on histones have been well characterized, and their role in enhancing or inhibiting specific gene expression was clearly elucidated. In the present review article, the critical roles of different histone modifications that occur in atherosclerosis have been summarized. Different histone proteins have been identified to serve a critical role in the development of atherosclerosis. Specifically, histone methylation and histone acetylation in monocytes, macrophages, vascular smooth muscle cells and in endothelial cells during the progression of atherosclerosis, have been well reported. In recent years, different target molecules and genes that regulate histone modifications have been examined for their effects in the treatment of atherosclerosis in animal models and in clinical trials. An increasing body of evidence suggests that these epigenetic changes resulting from DNA methylation and non‑coding RNA may also be associated with histone modifications, thereby indicating that novel therapeutic strategies can be developed by targeting these post translational modifications, which may in turn aid in the treatment of atherosclerosis.
View Figures
View References

Related Articles

Journal Cover

August-2018
Volume 18 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiang W, Agrawal DK and Boosani CS: Cell‑specific histone modifications in atherosclerosis (Review). Mol Med Rep 18: 1215-1224, 2018
APA
Jiang, W., Agrawal, D.K., & Boosani, C.S. (2018). Cell‑specific histone modifications in atherosclerosis (Review). Molecular Medicine Reports, 18, 1215-1224. https://doi.org/10.3892/mmr.2018.9142
MLA
Jiang, W., Agrawal, D. K., Boosani, C. S."Cell‑specific histone modifications in atherosclerosis (Review)". Molecular Medicine Reports 18.2 (2018): 1215-1224.
Chicago
Jiang, W., Agrawal, D. K., Boosani, C. S."Cell‑specific histone modifications in atherosclerosis (Review)". Molecular Medicine Reports 18, no. 2 (2018): 1215-1224. https://doi.org/10.3892/mmr.2018.9142